跳至主要内容
临床试验/ACTRN12622000990729
ACTRN12622000990729招募中未知

A randomised controlled trial assessing the effect of the electronic smoking cessation resource Screen2Quit on the self-reported and biochemically verified quit rate in smokers undergoing lung cancer screening

The University of Queensland0 个研究点目标入组 690 人开始时间: 2022年7月14日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
690

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • Adults smokers who are eligible for lung cancer screening and are able to give informed consent, own a smartphone and a computer, are capable of downloading an app and have access to the internet

排除标准

  • Those who do not own a smartphone and/or do not have access to the internet. Smokers who are current users of a smoking cessation smartphone app.

研究者

相似试验

Screen2Quit: An electronic smoking cessation... | 临床试验